Merger Notification - Announcement according to § 10 Cartel Act
Boston Scientific Corporation; Farapulse Inc.
BWB/Z-5503
On 30.06.2021 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
By way of an exercise of a call option, Boston Scientific Corporation, USA, intends to increase its current indirect minority shareholding in Farapulse Inc., USA, from 27% of the shares to 100% and acquire sole control over the target.
The concentration concerns the manufacture and supply of pulsed field ablation systems
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 28.07.2021.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 29.07.2021 .